These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1910449)

  • 1. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen.
    Cole BC; Atkin CL
    Immunol Today; 1991 Aug; 12(8):271-6. PubMed ID: 1910449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.
    Cole BC; Kartchner DR; Wells DJ
    J Immunol; 1990 Jan; 144(2):425-31. PubMed ID: 2136890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of transfected fibroblasts and transgenic mice establishes that stimulation of T cells by the Mycoplasma arthritidis mitogen is mediated by E alpha.
    Cole BC; David CS; Lynch DH; Kartchner DR
    J Immunol; 1990 Jan; 144(2):420-4. PubMed ID: 2295798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive properties of the Mycoplasma arthritidis T-cell mitogen in vivo: inhibition of proliferative responses to T-cell mitogens.
    Cole BC; Wells DJ
    Infect Immun; 1990 Jan; 58(1):228-36. PubMed ID: 1967168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of T cell activation induced by Mycoplasma arthritidis.
    Cole BC
    Isr J Med Sci; 1987 May; 23(5):496-502. PubMed ID: 3312095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunobiology of Mycoplasma arthritidis and its superantigen MAM.
    Cole BC
    Curr Top Microbiol Immunol; 1991; 174():107-19. PubMed ID: 1802617
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of Mycoplasma arthritidis superantigen with human T cells.
    Posnett DN; Hodtsev AS; Kabak S; Friedman SM; Cole BC; Bhardwaj N
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S170-5. PubMed ID: 8399910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoplasma arthritidis-derived superantigen.
    Rink L; Kirchner H
    Chem Immunol; 1992; 55():137-45. PubMed ID: 1418615
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM.
    Cole BC; Ahmed E; Araneo BA; Shelby J; Kamerath C; Wei S; McCall S; Atkin CL
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S163-9. PubMed ID: 8399909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VII. Responsiveness is associated with expression of a product(s) of the V beta 8 gene family present on the T cell receptor alpha/beta for antigen.
    Cole BC; Kartchner DR; Wells DJ
    J Immunol; 1989 Jun; 142(12):4131-7. PubMed ID: 2786024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens.
    Cole BC; Knudtson KL; Oliphant A; Sawitzke AD; Pole A; Manohar M; Benson LS; Ahmed E; Atkin CL
    J Exp Med; 1996 Mar; 183(3):1105-10. PubMed ID: 8642252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do superantigens play a role in autoimmunity?
    Posnett DN
    Semin Immunol; 1993 Feb; 5(1):65-72. PubMed ID: 8467097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell responses to Mycoplasma arthritidis-derived superantigen.
    Bhardwaj N; Hodtsev AS; Nisanian A; Kabak S; Friedman SM; Cole BC; Posnett DN
    Infect Immun; 1994 Jan; 62(1):135-44. PubMed ID: 8262619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide.
    Atkin CL; Wei S; Cole BC
    Infect Immun; 1994 Dec; 62(12):5367-75. PubMed ID: 7960116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR2 and TLR4 differentially regulate B7-1 resulting in distinct cytokine responses to the mycoplasma superantigen MAM as well as to disease induced by Mycoplasma arthritidis.
    Mu HH; Humphreys J; Chan FV; Cole BC
    Cell Microbiol; 2006 Mar; 8(3):414-26. PubMed ID: 16469054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.
    Cole BC; Sawitzke AD; Ahmed EA; Atkin CL; David CS
    Infect Immun; 1997 Oct; 65(10):4190-8. PubMed ID: 9317026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells.
    Friedman SM; Crow MK; Tumang JR; Tumang M; Xu YQ; Hodtsev AS; Cole BC; Posnett DN
    J Exp Med; 1991 Oct; 174(4):891-900. PubMed ID: 1833503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Mycoplasma arthritidis-derived mitogen to human MHC class II molecules via its N terminus is modulated by invariant chain expression and its C terminus is required for T cell activation.
    Langlois MA; Etongué-Mayer P; Ouellette M; Mourad W
    Eur J Immunol; 2000 Jun; 30(6):1748-56. PubMed ID: 10898513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM.
    Cole BC; Griffiths MM
    Arthritis Rheum; 1993 Jul; 36(7):994-1002. PubMed ID: 8318046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line.
    al-Daccak R; Mehindate K; Hébert J; Rink L; Mecheri S; Mourad W
    Infect Immun; 1994 Jun; 62(6):2409-16. PubMed ID: 8188366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.